This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Permissions Request Permissions Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (7) Citing Articles via Google Scholar Google Scholar Articles by Schleicher, G. K. Articles by Feldman, C. Search for Related Content PubMed PubMed Citation Articles by Schleicher, G. K. Articles by Feldman, C.

Procalcitonin and C-reactive protein levels in HIV-positive subjects with tuberculosis and pneumonia

¹ Dept of Medicine, Johannesburg Hospital and University of the Witwatersrand, ² AMPATH, and ³ School of Statistics and Actuarial Science, University of the Witwatersrand, Johannesburg, South Africa

CORRESPONDENCE: G. K. Schleicher, PO Box 98818, Sloane Park, 2152, South Africa. Fax: 27 114825984. E-mail: schleicher@worldonline.co.za

Keywords: C-reactive protein, HIV, pneumococcal pneumonia, procalcitonin, tuberculosis

Received: June 8, 2004
Accepted December 20, 2004

Pulmonary tuberculosis (PTB) and pneumococcal community-acquired pneumonia (PCAP) are common causes of lower respiratory tract infections in HIV-seropositive patients and may have similar clinical and radiological features. This study aimed to assess the value of serum procalcitonin (PCT) and C-reactive protein (CRP) levels in HIV-seropositive patients with pneumonia, and to investigate their potential role in differentiating pneumococcal from mycobacterial infections.

HIV-seropositive patients admitted with pneumonia were evaluated prospectively, 34 with PTB and 33 with PCAP.

All 33 patients in the PCAP group and 20 of 34 patients in the PTB group had elevated PCT levels (>0.1 ng·mL^–1). All patients in both groups had elevated CRP levels (>10 mg·L^–1). The PTB group had significantly lower CD4 T-lymphocyte counts, lower CRP levels, lower white cell counts, and lower PCT levels than the PCAP group. Receiver operating characteristic analysis showed that optimal discrimination between PTB and PCAP could be performed at a cut-off point of 3 ng·mL^–1 for PCT (sensitivity 81.8%; specificity 82.35%) and 246 mg·L^–1 for CRP (sensitivity 78.8%; specificity 82.3%).

In conclusion, HIV-seropositive patients with pneumococcal community-acquired pneumonia had significantly higher procalcitonin and C-reactive protein levels than those with pulmonary tuberculosis. A procalcitonin level >3 ng·mL^–1 and a C-reactive protein level >246 mg·L^–1 were both highly predictive of pneumococcal infection.

This article has been cited by other articles:

				R. Kannangai, A. J. Kandathil, D. L. Ebenezer, E. Mathai, A. J. Prakash, O. C. Abraham, T. D. Sudarsanam, S. A. Pulimood, R. Selvakumar, V. Job, et al. Usefulness of Alternate Prognostic Serum and Plasma Markers for Antiretroviral Therapy for Human Immunodeficiency Virus Type 1 Infection Clin. Vaccine Immunol., January 1, 2008; 15(1): 154 - 158. [Abstract] [Full Text] [PDF]